| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910260447.5ACN111763261B (en) | 2019-04-02 | 2019-04-02 | Fusion protein and application thereof |
| PCT/CN2020/082861WO2020200256A1 (en) | 2019-04-02 | 2020-04-01 | Fusion protein and use thereof |
| Publication Number | Publication Date |
|---|---|
| SG11202110400QAtrue SG11202110400QA (en) | 2021-10-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110400QASG11202110400QA (en) | 2019-04-02 | 2020-04-01 | Fusion protein and use thereof |
| Country | Link |
|---|---|
| US (1) | US20220251154A1 (en) |
| EP (1) | EP3950720A4 (en) |
| JP (1) | JP2022527705A (en) |
| KR (1) | KR20210146916A (en) |
| CN (2) | CN111763261B (en) |
| AU (1) | AU2020250613A1 (en) |
| BR (1) | BR112021019570A2 (en) |
| CA (1) | CA3131075A1 (en) |
| SG (1) | SG11202110400QA (en) |
| WO (1) | WO2020200256A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3201518A1 (en)* | 2020-11-18 | 2022-05-27 | Suzhou Transcenta Therapeutics Co., Ltd. | Bi-functional molecules |
| EP4296284A4 (en)* | 2021-02-19 | 2025-03-05 | SHAPERON Inc. | SINGLE-DOMAIN BISPECIFIC ANTIBODY AGAINST PD-L1 AND CD47 AND ITS USE |
| CN113773401B (en)* | 2021-09-15 | 2023-06-20 | 宜明昂科生物医药技术（上海）股份有限公司 | Recombinant fusion protein targeting CD47 and PD-L1 and preparation and application thereof |
| WO2023072279A1 (en)* | 2021-11-01 | 2023-05-04 | 江苏先声药业有限公司 | Sirpa mutant and application thereof |
| CN116178561B (en)* | 2021-11-26 | 2025-07-18 | 杭州尚健生物技术有限公司 | Fusion proteins comprising SIRPalpha mutants |
| WO2025002429A1 (en)* | 2023-06-28 | 2025-01-02 | 北京哲源科技有限责任公司 | Bispecific antibody targeting pd-l1 and il-1 and use thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
| CN101848929A (en)* | 2007-05-25 | 2010-09-29 | 诺华有限公司 | Streptococcus pneumoniae pilus antigens |
| CN103608684B (en)* | 2011-05-12 | 2016-05-04 | 基因泰克公司 | A Multiple Reaction Monitoring LC-MS/MS Method for the Detection of Therapeutic Antibodies in Animal Samples Using Framework Signature Peptides |
| EP3188758B1 (en)* | 2014-08-08 | 2023-10-04 | The Board of Trustees of the Leland Stanford Junior University | Sirp alpha-antibody fusion proteins |
| CN106535914B (en)* | 2014-08-08 | 2021-08-27 | Alx 肿瘤生物技术公司 | SIRP-alpha variant constructs and uses thereof |
| ES2751915T5 (en)* | 2014-08-15 | 2022-12-23 | Merck Patent Gmbh | Immunoglobulin fusion proteins with SIRP alpha |
| WO2017025498A1 (en)* | 2015-08-07 | 2017-02-16 | Pieris Pharmaceuticals Gmbh | Novel fusion polypeptide specific for lag-3 and pd-1 |
| BR102016018074A2 (en)* | 2015-08-07 | 2021-11-16 | ALX Oncology Inc. | SIRP-ALFA VARIANT CONSTRUCTION, ITS METHOD OF PREPARATION AND USES, NUCLEIC ACID MOLECULE, VECTOR, HOST CELL, AND PHARMACEUTICAL COMPOSITION |
| BR112018001353A2 (en)* | 2015-08-07 | 2018-09-11 | Alexo Therapeutics, Inc. | constructs having a sirp-alpha domain or variant thereof |
| CN107459578B (en)* | 2016-05-31 | 2021-11-26 | 泰州迈博太科药业有限公司 | Difunctional fusion protein targeting CD47 and PD-L1 |
| CN106967172B (en)* | 2016-08-23 | 2019-01-08 | 康方药业有限公司 | The anti-PD-1 bifunctional antibody of anti-CTLA 4-, its medical composition and its use |
| AU2017371070B2 (en)* | 2016-12-09 | 2025-01-02 | Alector Llc | Anti-SIRP-alpha antibodies and methods of use thereof |
| JP7296367B2 (en)* | 2017-05-08 | 2023-06-22 | シャンハイ ジェイエムティー－バイオ テクノロジー カンパニー リミテッド | Bispecific recombinant protein and its application |
| CN110386984B (en)* | 2018-04-17 | 2022-04-22 | 杭州尚健生物技术有限公司 | Fusion protein combined with CD47 protein and application thereof |
| CN111303293B (en)* | 2018-11-14 | 2022-08-30 | 杭州尚健生物技术有限公司 | Fusion protein and application thereof |
| CN109535263B (en)* | 2018-12-04 | 2022-06-17 | 江苏东抗生物医药科技有限公司 | SIRP alpha mutant and fusion protein thereof |
| CN109517054B (en)* | 2018-12-04 | 2022-04-08 | 江苏东抗生物医药科技有限公司 | SIRP alpha variant or fusion protein thereof and application thereof |
| Publication number | Publication date |
|---|---|
| CN113631582A (en) | 2021-11-09 |
| EP3950720A1 (en) | 2022-02-09 |
| CN111763261A (en) | 2020-10-13 |
| BR112021019570A2 (en) | 2021-11-30 |
| AU2020250613A1 (en) | 2021-11-11 |
| CA3131075A1 (en) | 2020-10-08 |
| JP2022527705A (en) | 2022-06-03 |
| CN111763261B (en) | 2022-08-09 |
| US20220251154A1 (en) | 2022-08-11 |
| CN113631582B (en) | 2024-09-06 |
| KR20210146916A (en) | 2021-12-06 |
| WO2020200256A1 (en) | 2020-10-08 |
| EP3950720A4 (en) | 2023-04-12 |
| Publication | Publication Date | Title |
|---|---|---|
| IL288373A (en) | Flt3l-fc fusion proteins and methods of use | |
| IL279510A (en) | Progranulin-fc polypeptide fusion proteins and uses thereof | |
| IL280102A (en) | Pd1-4-1bbl variant fusion protein and methods of use thereof | |
| EP3806889A4 (en) | Cytokine fusion proteins and uses thereof | |
| SG11202012004SA (en) | Rna-targeting fusion protein compositions and methods for use | |
| KR102201086B9 (en) | Il-2 cd80 fusion protein comprising il-2 protein and cd80 protein and use thereof | |
| IL267861A (en) | A pd1-41bbl fusion protein and methods of use thereof | |
| SG11202104912SA (en) | Fusion protein and use thereof | |
| IL280103A (en) | Sirpalpha-4-1bbl variant fusion protein and methods of use thereof | |
| SG11202110400QA (en) | Fusion protein and use thereof | |
| IL275248B1 (en) | Therapeutic enzyme fusion protein having a novel structure and use thereof | |
| IL267862A (en) | A sirpalpha-41bbl fusion protein and methods of use thereof | |
| IL284679A (en) | Multi-functional fusion proteins and uses thereof | |
| ZA202101250B (en) | Novel crispr-associated protein and use thereof | |
| EP3960756A4 (en) | Flagellin fusion protein and use thereof | |
| ZA202000595B (en) | Novel therapeutic enzyme fusion protein and use thereof | |
| EP3816186A4 (en) | Pd-l1-binding polypeptide and use thereof | |
| IL279057A (en) | Endolysin-containing antimicrobial fusion proteins and uses thereof | |
| GB2600592B (en) | Polypeptide and use thereof | |
| ZA202100092B (en) | Modified cas9 protein and use thereof | |
| ZA202102533B (en) | Fusion protein | |
| GB202201003D0 (en) | Fusion polypeptide and use thereof | |
| IL290715A (en) | Nkg2d fusion proteins and uses thereof | |
| IL286799A (en) | Fusion constructs and uses thereof | |
| GB202201004D0 (en) | Reconbinant fusion polypeptide and use thereof |